UBS Group Raises LifeStance Health Group (NASDAQ:LFST) Price Target to $9.00

Key Points

• UBS Group has increased its price target for LifeStance Health Group (NASDAQ:LFST) from $8.50 to $9.00, indicating a potential upside of 108.09% from the company's previous close.
• LifeStance Health reported a quarterly earnings per share of ($0.01), surpassing analysts' estimates and showing a year-over-year revenue growth of 10.6%.
• Institutional investors currently hold 85.50% of LifeStance Health's stock, reflecting significant interest and investment from larger financial entities.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) had its price objective increased by equities research analysts at UBS Group from $8.50 to $9.00 in a research note issued on Friday,Benzinga reports. The firm presently has a "buy" rating on the stock. UBS Group's price objective would suggest a potential upside of 108.09% from the company's previous close.

Separately, BTIG Research started coverage on LifeStance Health Group in a research report on Friday, July 25th. They set a "buy" rating and a $8.00 price objective on the stock. One research analyst has rated the stock with a sell rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $8.50.

LifeStance Health Group Price Performance

NASDAQ:LFST traded up $0.47 during mid-day trading on Friday, reaching $4.33. The stock had a trading volume of 3,729,210 shares, compared to its average volume of 1,888,585. LifeStance Health Group has a 12 month low of $3.74 and a 12 month high of $8.61. The stock has a market capitalization of $1.68 billion, a PE ratio of -43.25 and a beta of 1.13. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.47 and a quick ratio of 1.47. The stock has a 50-day simple moving average of $4.80 and a two-hundred day simple moving average of $6.22.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.02. The company had revenue of $345.31 million during the quarter, compared to analysts' expectations of $345.05 million. LifeStance Health Group had a negative return on equity of 2.47% and a negative net margin of 2.78%. LifeStance Health Group's revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.06) EPS. On average, equities analysts anticipate that LifeStance Health Group will post -0.18 earnings per share for the current year.

Insider Activity at LifeStance Health Group

In other news, insider Ujjwal Ramtekkar sold 16,000 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the transaction, the insider directly owned 113,435 shares of the company's stock, valued at $673,803.90. This represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.20% of the stock is currently owned by corporate insiders.

Institutional Trading of LifeStance Health Group

A number of hedge funds and other institutional investors have recently bought and sold shares of LFST. DekaBank Deutsche Girozentrale purchased a new stake in LifeStance Health Group in the 1st quarter valued at $31,000. Park Edge Advisors LLC purchased a new stake in shares of LifeStance Health Group in the second quarter valued at about $52,000. Xponance Inc. bought a new position in shares of LifeStance Health Group during the first quarter valued at about $69,000. Public Employees Retirement System of Ohio bought a new position in shares of LifeStance Health Group during the second quarter valued at about $70,000. Finally, Blair William & Co. IL purchased a new position in LifeStance Health Group during the second quarter worth about $70,000. Institutional investors own 85.50% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.